Understanding Acquired Generalized Lipodystrophy (AGL)

Being diagnosed with Acquired Generalized Lipodystrophy (AGL), also known as Lawrence Syndrome, can feel like your body has suddenly become a stranger. You may have noticed a rapid, dramatic change in your appearance as body fat seems to vanish from your face, arms, legs, and, for female patients, breast tissue ^[1][2].

It is important to understand right away: this is not your fault. AGL is not caused by your diet, your exercise habits, or anything you did or did not do. It is a rare, complex medical condition where your immune system or an underlying biological process mistakenly destroys your adipose tissue (fat cells) ^[3][4].

Understanding Your Diagnosis

In a healthy body, fat cells do much more than just store calories; they act as a vital endocrine organ. They produce a hormone called leptin, which tells your brain when you are full and helps your body manage insulin and sugar ^[5].

In AGL, these fat cells disappear. Because the body can no longer store fat in the “right” places under the skin, it begins to store it in the “wrong” places—like the liver and muscles. This is called ectopic lipid accumulation ^[5]. This “displaced” fat causes the metabolic challenges often seen with AGL, such as severe insulin resistance and high triglycerides ^[6][7]. You can read more about these physical changes in the Symptoms and Warning Signs section.

Clearing Up Misconceptions

Because AGL causes a very lean appearance, it is sometimes misunderstood by those who don’t know the science.

• It is NOT an eating disorder: Unlike conditions like anorexia nervosa, where weight loss is driven by calorie restriction, AGL is a physical loss of the fat-storage “containers” themselves ^[8]. In fact, people with AGL often have extremely low levels of leptin, which can lead to hyperphagia—a medical term for intense, constant hunger ^[9].
• It is NOT “congenital”: While some forms of lipodystrophy are present at birth due to genetics, AGL is “acquired,” meaning it typically begins later in life, often during childhood, adolescence, or young adulthood ^[1][10].
• It is extremely rare: AGL is so rare that many doctors may never see a case in their entire careers.

Setting Expectations for Treatment

The primary goal of care is to manage the “metabolic fallout” caused by the lack of fat cells and the resulting leptin deficiency. It is crucial to know up front that treatments are designed to save your internal organs and stabilize your metabolism—they generally do not reverse the physical fat loss or restore subcutaneous fat ^[11].

The most significant advancement in treating AGL is metreleptin (brand name Myalept). This is a recombinant (man-made) version of the leptin your body is missing, delivered as a daily subcutaneous (under-the-skin) injection ^[11].

• Restoring Balance: Metreleptin helps “replace” the missing hormone signal, which can significantly improve insulin sensitivity and lower blood sugar levels ^[9][12].
• Protecting the Liver: By helping the body process fats correctly, it can reduce the amount of fat stored in the liver (hepatic steatosis) and lower dangerously high triglycerides ^[13][14].
• Managing Hunger: It can also help quiet the intense, constant hunger that many patients experience ^[9].

To learn more about how AGL works and the specific subtypes (like autoimmune or medication-induced AGL), visit The Biology and Diagnosis of AGL. For more details on the injection, side effects, and how to access this medication, read about Treating the Metabolic Fallout.